Newbury Pharmaceuticals engages Pareto Securities to reduce spread in share price

MFN Publicerad: 05 Sep 2022 15:00

Newbury Pharmaceuticals has entered into an agreement with Pareto Securities whereby Pareto Securities will act as liquidity provider for the Newbury share. The assignment takes place within the framework of Nasdaq First North Growth Market's liquidity provision rules and means that the liquidity provider quotes a buy and sell volume corresponding to at least SEK 15,000, with a maximum spread of 4% between the bid and ask price. The purpose is to promote the share's liquidity, and the assignment commences on Tuesday, September 6th, 2022.

About Newbury Pharmaceuticals

Newbury Pharmaceuticals is building a pipeline of proprietary and licensed products with focus on specialty and branded products in the Nordics. Newbury aims to make a difference by offering treatment solutions within areas like oncology, rare diseases and neurology. The portfolio is built by leveraging experience and extensive international network. Newbury offers strategic partnerships of innovation for the benefit of the Nordic healthcare market.

Västra Hamnen Corporate Finance is the Company's Certified Adviser on Nasdaq First North and can be reached at [email protected] or +46 (0) 40 200 250.

Börskollen

För dig med koll på börsen

Pressmeddelande

Newbury Pharmaceuticals engages Pareto Securities to reduce spread in share price

Bifogade filer

Nyheter om Newbury Pharmaceuticals

Läses av andra just nu

Om aktien Newbury Pharmaceuticals

Senaste nytt